Пемброриа - analogs
Components: Pembrolizumab |
|||||||||
Pharmgroups: Antitumor agents - monoclonal antibodies |
|||||||||
Prices in pharmacies: — Instructions Пемброриа | |||||||||
|
ⓘ✘Enter drugs for проверки взаимодействовий through a quick button search . Pentalgin ✘ (incl) Плодовые тела кордицепса ✘ (incl) Alomid ✘ (incl) Ferrum phosphoricum ✘ (incl) Медь-DS ✘ (incl) Силденафил-СЗ ✘ (incl) TWL Detox Fuel ✘ (incl) Eleutherococci extract siccum ✘ (incl) Madopar ✘ (incl) Pini extract naturale ✘ (incl) Paclitaxel ✘ (incl) Azelaic acid ✘ (incl) Phthorothanum ✘ (incl) Sedum acre ✘ (incl) Xanthoria parientina ✘ |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. |
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
Similar | Complete analog ⓘ✘Аналоги препарата с полностью совпадающими действующими веществами |
Prices in pharmacies |
≈100% | Keytruda Negative 🔍 | — |
-
Similar
Prices in
pharmaciesAnalogs by action ⓘ✘Analogues of the drug according to its degree of similarity with other drugs that are not direct analogues
- 44% 250-450€ Opdivo Negative 🔍 [Nivolumab]
- 41% — Лорвиква Negative 🔍 [Lorlatinib]
- 36% 100-300€ Ацеллбия Negative 🔍 [Rituximab]
- 36% 2103.9€ Mekinist neutral [Trametinib]
- 36% — Erlotinib - native neutral [Erlotinib]
- 35% 1906.2€ Gazyva Negative 🔍 [Obinutuzumab]
- 35% 2535.2€ Alecensa neutral [Alectinib]
- 32% — Erlotinib neutral [Erlotinib]
- 32% — Imfinzi Negative 🔍 [Durvalumab]
- 31% 1846.9-2647.4€ Tecentriq Negative 🔍 [Atezolizumab]
- 30% 838€ Tarceva neutral [Erlotinib]
- 28% — Vinorelbine medac Negative 🔍 [Vinorelbine]
- 28% — Vinorelbine bitartrate Negative 🔍 [Vinorelbine]
- 28% — Vincarelbine Negative 🔍 [Vinorelbine]
- 28% 13.3-426€ Bevacizumab Negative 🔍 [Bevacizumab]
- 28% — Vinorelbine tartrate Negative 🔍 [Vinorelbine]
- 28% 80-300€ Авегра БИОКАД Negative 🔍 [Bevacizumab]
- 28% — Версаво Negative 🔍 [Bevacizumab]
- 28% 1645€ Cyramza Negative 🔍 [Ramucirumab]
- 27% 1296.2-2074.1€ Kadcyla Negative 🔍 [Trastuzumab emtansine]
- 27% — Tarlenib neutral [Erlotinib]
- 27% 300-516€ Herceptin Negative 🔍 [Trastuzumab]
- 26% 89.9-339.6€ Avastin Negative 🔍 [Bevacizumab]
- 26% 3603.1€ Ервой Negative 🔍 [Ipilimumab]
- 25% — Пеметрекседа динатрия гемипентагидрат Dangerous 🔍 [Pemetrexed]
- 25% — Пеметрексед-промомед Dangerous 🔍 [Pemetrexed]
- 25% — Metinur Negative 🔍 [Nitrosomethylurea]
- 25% — Cetuximab Negative 🔍 [Cetuximab]
- 25% 220€ Trastuzumab Negative 🔍 [Trastuzumab]
- 25% 108-345.8€ Тразимера Negative 🔍 [Trastuzumab]
- 25% 114.6-230€ Herticad Negative 🔍 [Trastuzumab]
- 25% — Pemetrexed disodium Dangerous 🔍 [Pemetrexed]
- 25% 407.7€ Pemetrexed Dangerous 🔍 [Pemetrexed]
- 25% — Фолитрекс Dangerous 🔍 [Pemetrexed]
- 25% — Pemetrexed-nativ Dangerous 🔍 [Pemetrexed]
- 25% — Verotrexed Dangerous 🔍 [Pemetrexed]
- 25% — Пемджем Dangerous 🔍 [Pemetrexed]
- 25% — Пеметрекседа динатрия гептагидрат Dangerous 🔍 [Pemetrexed]
- 25% 76.2-377.7€ Пемелан Dangerous 🔍 [Pemetrexed]
- 25% 447.2-480€ Alimta Dangerous 🔍 [Pemetrexed]
- 25% — Пеметрексед-Келун-Казфарм Dangerous 🔍 [Pemetrexed]
- 25% — Pemetrexed-TL Dangerous 🔍 [Pemetrexed]
- 25% — Пеметрексед Канон Dangerous 🔍 [Pemetrexed]
- 25% — Антифолат Dangerous 🔍 [Pemetrexed]
- 25% — Pemetrexed J Dangerous 🔍 [Pemetrexed]
- 25% — ИСПОЛАТ Dangerous 🔍 [Pemetrexed]
- 25% — Пеметрексед-ДЕКО Dangerous 🔍 [Pemetrexed]
- 25% — Пеметрексед-Рус Dangerous 🔍 [Pemetrexed]
- 25% 2264.6€ Adcetris neutral [Brentuximab Vedotin]
- 24% — Perjeta Negative 🔍 [Pertuzumab]
Learn more about the selection of analogues
- The drug has «Пемброриа» 1 full analog, for example Keytruda; 51 analog by action, the most similar - Opdivo (250-450€).
- Medical online service has selected the best substitutes for Пемброриа based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of Пемброриа analogues to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.